{
    "2018-07-30": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Johnson & Johnson Adds Zarbee’s Naturals to Bolster Consumer Brands",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Zarbee’s Naturals",
                        "Consumer Brands"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Celgene’s Revlimid and Pomalyst See Solid Growth",
                "features": {
                    "keywords": [
                        "Celgene",
                        "Revlimid",
                        "Pomalyst",
                        "Solid Growth"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "European Medicines Agency's CHMP Says Yes To 7 Drugs, No To 1",
                "features": {
                    "keywords": [
                        "European Medicines Agency",
                        "CHMP",
                        "Drugs Approval"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "regulatory"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}